The Digest’s 2026 Multi-Slide Guide to Strain Stability

Engineered strains frequently experience genetic drift under industrial conditions, leading to gradual, mid-life performance declines that remain invisible to standard month-to-month management reviews. This slow decay erodes cumulative titer and yield, threatening the long-term financial viability of assets and jeopardizing offtake or debt agreements. To de-risk commercial scale-up, operators must move beyond short-term milestones and actively design stability into the process. This requires utilizing long-horizon statistical process control, establishing cell-bank generation limits, and enforcing rigorous, continuous strain-monitoring protocols at scale.

<!–nextpage—> <!–nextpage—> <!–nextpage—> <!–nextpage—> <!–nextpage—> <!–nextpage—> <!–nextpage—> <!–nextpage—> <!–nextpage—> <!–nextpage—> <!–nextpage—> <!–nextpage—> <!–nextpage—> <!–nextpage—> <!–nextpage—> <!–nextpage—>

Category: Multi-Slide Guides